بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

أحمد عبدالرحيم احمد عبدالرحيم النجار

الموقع الشخصى

أحمد عبدالرحيم احمد عبدالرحيم النجار

الكلية الطب - القسم طب الأورام

الدرجات العلمية

بكالوريوس فى الطب والجراحه, -جامعة الزقازيق [2000]
ماجستير فى علاج الاورام, -جامعة الزقازيق [2005]
(دراسة الاختلال الجينى فى مرضى سرطان الدم الميلودى الحاد البالغين قبل العلاج كعامل تنبؤى للاستجابة المبدئية للعلاج)
دكتوراه فى علاج الاورام, -جامعة الزقازيق [2011]

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 3/3/2005
مدرس مساعد : 3/8/2005
مدرس : 23/8/2011
أستاذ مساعد : 30/8/2016
أستاذ : 28/9/2021

الأبحاث العلمية

1 - Significance of PAX (CDX2) gene expression in adult acute Myeloid leukemia (1436).

2 - Emergency Department Visits at the End of Life of Patients With Terminal Cancer (1436).

3 - The pattern of infection and antibiotics use in terminal cancer patients. (1435).

4 - Clinico-Pathological Patterns and Survival Outcome of Colorectal Cancer in Young Patients: Western Saudi Arabia Experience (1435).

5 - The Relation Between the Timing of Palliative Care and the Frequency and Timing of Do-Not-Resuscitate Orders Among Cancer Deaths in a Tertiary Care Hospital (1436).

6 - The fear of using tramadol for pain control (tramadolophobia) among Egyptian patients with cancer (1437).

7 - Role of reduced dose CHOP with Rituximab plus involved field radiotherapy in treatment of early stage diffuse large B –cell lymphoma in elderly patients (1437).

8 - Can Resection Of Liver Metastasis Improve Survival After Resectability Conversion Chemotherapy In Patients With Metastatic Colo-Rectal Cancer? (1437).

9 - The role of oncogenic infectious agents in causing liver, stomach, urinary bladder , head and neck and cervical cancers. (1437).

10 - Full donor chimerism without graft-versus-host disease: the key factor for maximum beneﬁt of pre-emptive donor lymphocyte infusions (pDLI) (1441).

11 - Full donor chimerism without graft-versus-host disease: the key factor for maximum beneﬁt of pre-emptive donor lymphocyte infusions (pDLI) (1441).

12 - ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy (1441).

13 - Brain and Acute Leukemia, Cytoplasmic Gene Overexpression as a Prognostic Factor in Egyptian De novo Adult Acute Myeloid Leukemia Patients (1442).

14 - Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study (1442).

15 - Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites (1442).

16 - Outcome of Core Binding Factor Acute Myeloid Leukemia by Receptor Tyrosine Kinase Mutation (1441).

17 - Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia (1438).

18 - Prognostic impact of immunohistochemical expression of claudin-4 and epithelial mesenchymal-related markers (Snail-1) in breast invasive duct carcinoma (1442).

المجالات البحثية